Back to Search
Start Over
Centella asiatica extract ameliorates deoxygenation-induced neurological dysfunction in zebrafish larvae.
- Source :
-
Open veterinary journal [Open Vet J] 2024 May; Vol. 14 (5), pp. 1154-1160. Date of Electronic Publication: 2024 May 31. - Publication Year :
- 2024
-
Abstract
- Background: Oxygen deprivation (OD) is a critical condition that can lead to brain damage and even death. Current hypoxia management approaches are limited in effectiveness. Centella asiatica (CA), known for its neuroprotective properties, offers a potential alternative for OD treatment.<br />Aims: This study aims to investigate the neuroprotective effects of CA on the expression of brain-derived neurotrophic factor (BDNF) and vesicular glutamate transporter 1 (VGLUT1) in zebrafish larvae under oxygen-deficient conditions.<br />Methods: Zebrafish embryos were subjected to low oxygen levels (1.5 mg/l) 0-2 hours post-fertilization (hpf) until 3 days post-fertilization (dpf), simulating the early stages of OD. Subsequent treatment involved varying concentrations of CA (1.25-5 µg/ml) up to 9 days post-fertilization. The expression levels of BDNF and VGLUT1 were measured using PCR methods. Statistical analysis was conducted using a two-way analysis of variance to evaluate the impact of CA on the expression of BDNF and VGLUT1 in zebrafish larvae aged 3 and 9 dpf in oxygen-deprived conditions.<br />Results: CA significantly influenced the expression of BDNF and VGLUT1 under OD ( p < 0.001). An increase in BDNF expression ( p < 0.001) and a decrease in VGLUT1 ( p < 0.01) were observed in zebrafish larvae experiencing OD and treated with CA. There was no significant difference in BDNF and VGLUT1 expression across age variations in zebrafish larvae at 3 dpf and 9 dpf in the treatment groups ( p > 0.05). CA concentration of 2.5 µg/ml effectively enhanced BDNF and reduced VGLUT1 in 3-9 dpf zebrafish larvae.<br />Conclusion: CA demonstrates potential as a neuroprotective agent, modulating increased BDNF expression and reduced VGLUT1 under OD conditions. These findings lay a foundation for further research in developing therapies for oxygen deficiency.<br />Competing Interests: The authors declare that there is no conflict of interest.
- Subjects :
- Animals
Neuroprotective Agents pharmacology
Oxygen metabolism
Fish Diseases chemically induced
Fish Diseases drug therapy
Hypoxia veterinary
Hypoxia drug therapy
Zebrafish
Centella chemistry
Plant Extracts pharmacology
Plant Extracts administration & dosage
Larva drug effects
Larva growth & development
Triterpenes pharmacology
Triterpenes administration & dosage
Brain-Derived Neurotrophic Factor metabolism
Brain-Derived Neurotrophic Factor genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2218-6050
- Volume :
- 14
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Open veterinary journal
- Publication Type :
- Academic Journal
- Accession number :
- 38938421
- Full Text :
- https://doi.org/10.5455/OVJ.2024.v14.i5.9